Novel metabolic signatures in renal cell carcinoma for precision diagnostics and therapeutics

被引：0
|
作者：
Amaro, F. [1 ,2 ]
Carvalho, M. [1 ,2 ,3 ]
Carvalho-Maia, C. [4 ,5 ]
Jeronimo, C. [4 ,5 ]
Henrique, R. [4 ,5 ,6 ]
Bastos, M. D. L. [1 ,2 ]
Guedes de Pinho, P. [1 ,2 ]
Pinto, J. [1 ,2 ]
机构：
[1] Univ Porto, Fac Pharm, Toxicol Lab, UCIBIO Appl Mol Biosci Unit, Porto, Portugal
[2] Univ Porto, Inst Hlth & Bioecon, Associate Lab I4HB, Porto, Portugal
[3] Univ Fernando Pessoa, RISE UFP, Fac Hlth Sci, Porto, Portugal
[4] Portuguese Oncol Inst Porto, Canc Biol & Epigenet Grp, Res Ctr CI IPOP, Porto Comprehens Canc Ctr P CCC, Porto, Portugal
[5] Portuguese Oncol Inst Porto IPO Porto, Dept Pathol, P CCC Porto Comprehens Canc Ctr, Porto, Portugal
[6] Univ Porto, ICBAS Sch Med & Biomed Sci, Dept Pathol & Mol Immunol, Porto, Portugal
来源：
TOXICOLOGY LETTERS | 2024年 / 399卷
关键词：
D O I：
10.1016/j.toxlet.2024.07.608
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
P18-08
引用
收藏
页码：S251 / S251
页数：1
相关论文
共 50 条
  • [1] Metabolic signatures of renal cell carcinoma
    Lim, Hwee Ying
    Yip, Yin Mun
    Chiong, Edmund
    Tiong, Ho Yee
    Halliwell, Barry
    Esuvaranathan, Kesavan
    Wong, Kim Ping
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 460 (04) : 938 - 943
  • [2] Novel Therapeutics for Metastatic Renal Cell Carcinoma
    Hutson, Thomas E.
    Figlin, Robert A.
    CANCER, 2009, 115 (10) : 2361 - 2367
  • [3] Epigenetics of renal cell carcinoma: the path towards new diagnostics and therapeutics
    Morris, Mark R.
    Maher, Eamonn R.
    GENOME MEDICINE, 2010, 2
  • [4] Epigenetics of renal cell carcinoma: the path towards new diagnostics and therapeutics
    Mark R Morris
    Eamonn R Maher
    Genome Medicine, 2
  • [5] Targeting ferroptosis in renal cell carcinoma: Potential mechanisms and novel therapeutics
    Yang, Lei
    Fan, Yu
    Zhang, Qian
    HELIYON, 2023, 9 (08)
  • [6] Modification of the Tumor Microenvironment as a Novel Target of Renal Cell Carcinoma Therapeutics
    Finke, James H.
    Rayman, Pat A.
    Ko, Jennifer S.
    Bradley, Judy M.
    Gendler, Sandra J.
    Cohen, Peter A.
    CANCER JOURNAL, 2013, 19 (04): : 353 - 364
  • [7] Immune Checkpoint Inhibitors as Novel Targets for Renal Cell Carcinoma Therapeutics
    Bailey, Alexandra
    McDermott, David F.
    CANCER JOURNAL, 2013, 19 (04): : 348 - 352
  • [8] Liquid biopsy for precision diagnostics and therapeutics
    Anitha, Kuttiappan
    Posinasetty, Bhargavi
    Kumari, K. Naveen
    Chenchula, Santenna
    Padmavathi, R.
    Prakash, Satya
    Radhika, Chikatipalli
    CLINICA CHIMICA ACTA, 2024, 554
  • [9] Screening and identification of novel promoter signatures in clear cell renal cell carcinoma metastasis
    Qu, Yuan-Yuan
    Tian, Xi
    Xu, Wenhao
    Anwaier, Aihemutaijiang
    Ye, Dingwei
    Zhang, Hailiang
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [10] New therapeutics strategies in renal cell carcinoma
    Meric, J. -B.
    Billemont, B.
    Rixe, O.
    BULLETIN DU CANCER, 2010, 97 : S53 - S63
12345